However, given that aberrant regulation of CCT subunits has also been implicated in cancer cell proliferation (Ghozlan et al., 2022), future research must prioritize understanding the context-dependent control of TRiC/CCT activity to ensure both efficacy and safety in clinical applications. This evidence concerns the gene FLVCR2 and cancer.